Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

By Staropoli I.   Frenkiel M.-P.   Megret F.   Deubel V.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1946-1954

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice

By Konishi E.   Yamaoka M.   Kurane I.   Mason P.W.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1133-1139

Elsevier

Access to resources Recommend Favorite

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

By Kilbourne E.D.   Couch R.B.   Kasel J.A.   Keitel W.A.   Cate T.R.   Quarles J.H.   Grajower B.   Pokorny B.A.   Johansson B.E.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1799-1803

Elsevier

Access to resources Recommend Favorite

Immunogenic and protective properties of chicken anaemia virus proteins expressed by baculovirus

By Koch G.   van Roozelaar D.J.   Verschueren C.A.J.   van der Eb A.J.   Noteborn M.H.M.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 763-770

Elsevier

Access to resources Recommend Favorite